MiMedx Group, Inc. (MDXG) News
Follow MiMedx Group, Inc. (MDXG) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 15 public stories across 5 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Mimedx Announces Favorable Federal Court Ruling In Axiofill® Regulatory Classification Matter
MiMedx Group, Inc. NASDAQ:MDXG
NEWS | Sep 23, 2026, 09:07 PM UTC
L
MiMedx Gets Favorable Court Ruling in FDA Treatment-Classification Dispute
By Katherine HamiltonMiMedx said it received a favorable ruling in its litigation challenging the Food and Drug Administration's classification of its wound treatment Axiofill.A Georgia district court ruled against the F
REGULATION | Sep 23, 2026, 08:31 PM UTC
L
MiMedx Group: Court Remands Both Matters to FDA for Further Consideration Consistent With Order >MDXG
MiMedx Group: Court Remands Both Matters to FDA for Further Consideration Consistent With Order >MDXG
REGULATION | Sep 23, 2026, 08:04 PM UTC
L
MiMedx Group: Court Vacates FDA Determinations That Axiofill Isn't Minimally Manipulated, Should Be Classified as Biological Product
MiMedx Group: Court Vacates FDA Determinations That Axiofill Isn't Minimally Manipulated, Should Be Classified as Biological Product
REGULATION | Sep 23, 2026, 08:03 PM UTC
L
MiMedx Group, Inc. (MDXG) Wins Ruling Vacating FDA AXIOFILL Decisions
A U.S. District Court vacated FDA determinations that AXIOFILL is not minimally manipulated and should be a biological product, and remanded the matter to FDA for reconsideration consistent with the order.Material Detail
REGULATION | Sep 23, 2026, 08:03 PM UTC
L
MIMEDX Announces Favorable Federal Court Ruling in AXIOFILL® Regulatory Classification Matter
Court Vacates FDA Determinations That AXIOFILL Is Not Minimally Manipulated and Should Be Classified as a Biological ProductOrder Further Holds That Minimal-Manipulation Analysis Must Consider Tissue Characteristics Rele
REGULATION | Sep 23, 2026, 08:02 PM UTC
L
MDXG - MIMEDX Announces Favorable Federal Court Ruling in AXIOFILL® Regulatory Classification Matter
MDXG - MIMEDX Announces Favorable Federal Court Ruling in AXIOFILL® Regulatory Classification Matter
NEWS | Sep 23, 2026, 08:01 PM UTC
L
MiMedx management to participate in investor conferences on Sept. 9
MiMedx Group, Inc. said members of senior management will participate in the Cantor Global Healthcare Conference in New York on Wednesday, September 9, 2026.
EQUITY | Sep 08, 2026, 12:07 PM UTC
L
MDXG - MIMEDX to Participate in Upcoming Investor Conferences
MDXG - MIMEDX to Participate in Upcoming Investor Conferences
EQUITY | Sep 08, 2026, 12:01 PM UTC
L
MiMedx Group maintained at Buy by Craig-Hallum
Craig-Hallum maintained its Buy rating on MiMedx Group.
EQUITY | Aug 27, 2026, 06:50 PM UTC
H
Meta Posts Mixed Q2 Results, Joins Coursera, Qualcomm And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining around 0.2% on Thursday. Shares of Meta Platforms Inc (NASDAQ: META ) fell sharply in pre-market trading after the company posted mixed financial
EARNINGS | Jul 30, 2026, 12:03 PM UTC
L
MiMedx Group Affirms FY2026 Sales Guidance of $260.000M-$290.000M vs $269.440M Est
MiMedx Group (NASDAQ: MDXG ) affirms FY2026 sales outlook from $260.000 million-$290.000 million to $260.000 million-$290.000 million vs $269.440 million estimate.
EARNINGS | Jul 29, 2026, 08:13 PM UTC
L
MDXG - MIMEDX Announces Second Quarter 2026 Operating & Financial Results
MDXG - MIMEDX Announces Second Quarter 2026 Operating & Financial Results
EQUITY | Jul 29, 2026, 08:07 PM UTC
L
SMTI MDXG Mimedx to acquire Sanara Medtech Sanara Medtech - Mimedx to buy Sanara in deal valued at $35 per share, enterprise value $350M San
SMTI MDXG Mimedx to acquire Sanara Medtech Sanara Medtech - Mimedx to buy Sanara in deal valued at $35 per share, enterprise value $350M Sanara Medtech - Mimedx to finance deal with cash on hand and $300M term loan from
EARNINGS | Jul 29, 2026, 08:03 PM UTC
L
MDXG - MIMEDX to Acquire Sanara MedTech
MDXG - MIMEDX to Acquire Sanara MedTech
MNA | Jul 29, 2026, 08:01 PM UTC